Filter Results:
(155)
Show Results For
- All HBS Web
(155)
- News (54)
- Research (98)
- Events (1)
- Multimedia (1)
- Faculty Publications (61)
Show Results For
- All HBS Web
(155)
- News (54)
- Research (98)
- Events (1)
- Multimedia (1)
- Faculty Publications (61)
- 08 Apr 2009
- Research & Ideas
Clayton Christensen on Disrupting Health Care
screening participants in drug trials and make it possible to track and troubleshoot unexpected problems that show up after a drug is introduced into the general population,... View Details
- 05 May 2020
- News
“Walking a Tightrope”
Kristof, most of which have focused on poverty in developing countries. But in the Pulitzer Prize-winning duo’s latest book, Tightrope: Americans Reaching for Hope, they turn their lens on working class communities in the United States—communities that have been... View Details
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
who spent six years commercializing drugs and diagnostics in East and West Africa before earning her MBA. “There are frequently delays in diagnosis, where the turnaround time for a biopsy could be several weeks or months.” That lag time,... View Details
Keywords: Susan Young
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
Abstract—Objective: Assess whether a commitment contract informed by behavioral economics leads to persistent virologic suppression among HIV-positive patients with poor antiretroviral therapy (ART) adherence. Design: Single-center pilot randomized clinical View Details
Keywords: Sean Silverthorne
- Web
Student Spotlight: From Nigeria to HBS: Reigniting My Passion for Healthcare Innovation - Blog: Health Supplement
Practitioners Topics Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship Health Care Innovation Health Care Investment Health Care at HBS Insurance/payor Medical... View Details
- 12 Feb 2019
- First Look
New Research and Ideas, February 12, 2019
Devices: Challenges and Opportunities for U.S. Regulators and Innovators By: Gordon, William J., and Ariel Dora Stern Abstract— Software has become an increasingly important component of medical device technology. Through legislation like the 21st Century Cures Act as... View Details
Keywords: Dina Gerdeman
- 01 May 2007
- First Look
First Look: May 1, 2007
face major challenges including headline-grabbing litigation, imminent patent expirations, new technologies, rising drug development costs, generic drug substitution, international competitors, and complex... View Details
Keywords: Sean Silverthorne
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
companies, complete and accurate patient data would help in screening participants in drug trials and make it possible to track and troubleshoot unexpected problems that show up after a View Details
- 14 Apr 2021
- Research & Ideas
The High Cost of the Slow COVID Vaccine Rollout
dollars in value, Kominers and his co-authors reported in Market Design to Accelerate COVID-19 Vaccine Supply in the March 12 issue of Science. “The value of being able to produce vaccines at scale the minute they clear trials is... View Details
- 01 Dec 2009
- News
Seven Honored with Alumni Achievement Award
Merck, Gillette, and Searle, Kathy Giusti was diagnosed in 1996 with multiple myeloma, a rare and incurable blood cancer. She then founded the Multiple Myeloma Research Foundation and the Multiple Myeloma Research Consortium, organizations that have revolutionized... View Details
- 05 Jul 2004
- Research & Ideas
Radical Change, Entrepreneurial Opportunity
tightly coupled relationships with customers to engage in trials of different product concepts, producers and users can jointly learn about and make sense of the new technology. For instance, Surface Logix, a firm with highly... View Details
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
cause of blindness. In October 2009 the company entered into licensing and purchase option agreements with Alcon, which is now taking Potentia's drug candidate through Clinical 2 trials with a to-market goal... View Details
- 01 Jun 2011
- News
The Best-Laid Plans
in on a treatment for age-related macular degeneration, a leading cause of blindness. In October 2009 the company entered into licensing and purchase option agreements with Alcon, which is now taking Potentia’s drug candidate through... View Details
- 13 Jan 2009
- First Look
First Look: January 13, 2009
persevered and thrived despite personal, social, and professional obstacles. Purchase this case: http://harvardbusinessonline.hbsp.harvard.edu/ b01/en/common/item_detail.jhtml?id=409057 A Managerial Perspective on Clinical Trials Harvard... View Details
Keywords: Martha Lagace
- 23 Jan 2019
- News
The Promise of Personalized Medicine
and a 501(c)(3) called Cure Rare Disease. With the foundation, Horgan is trying to build something radical: A model for personalizing drug development, with the hopes of saving not only his brother but countless others. READ MORE Morrell:... View Details
- 17 Oct 2006
- First Look
First Look: October 17, 2006
businesses will flounder. The authors describe the challenges companies face when they pursue new businesses, as well as the usual problematic responses to those challenges. Such companies, they say, must perform three balancing acts: 1) Develop strategy by View Details
Keywords: Sean Silverthorne
- 27 Mar 2012
- First Look
First Look: March 27
services will become its key competitive advantage in the decade to come. This case traces the evolution of the CRO sector from a small, secondary cluster of firms into a major player with essential capabilities for global drug... View Details
Keywords: Carmen Nobel
- 15 Dec 2015
- News
The Year in Ideas 2015
to something big. After a second field study, Solomon and Hillerstrom launched NeuroPhage. In tests on mice, the drug they developed improved both memory and cognitive abilities. “We believe it can identify harmful aggregates in the... View Details
- 01 Jun 2018
- News
June 2018 Alumni and Faculty Books
damaged the US’s social psyche, as did widespread drug use and chemical dependency. Vivid pictures of violence in Vietnam on TV plus incessant riots in major US cities began to blur the differences between crime, punishment, and... View Details
- 28 Apr 2009
- First Look
First Look: April 28, 2009
consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based... View Details
Keywords: Martha Lagace